Metabolic reprogramming of Th17/Treg imbalance in autoimmune thyroid diseases
Authors:
Top Cited Papers
Open Access
- 29 April 2026
- journal article
- review article
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 24 (1)
Abstract
Autoimmune thyroid diseases (AITDs), including Hashimoto’s thyroiditis and Graves’ disease, arise from thyroid-specific autoimmunity driven byKeywords
Funding Information
- Jiangsu Provincial Medical Key Discipline Cultivation Unit (JSDW202241)
- Science and Technology Planning Social Development Project of Zhenjiang City (SH2025033)
This publication has 183 references indexed in Scilit:
- Molecular pathway and mechanism responsible for the progress of thyroid-associated orbitopathyInternational Ophthalmology, 2025
- Causality of blood metabolites and metabolic pathways on Graves’ disease and Graves’ ophthalmopathy: a two-sample Mendelian randomization studyEndocrine, 2024
- m6A mRNA modification potentiates Th17 functions to inflame autoimmunityScience China Life Sciences, 2023
- Short-chain fatty acid-mediated epigenetic modulation of inflammatory T cells in vitroDrug Delivery and Translational Research, 2022
- The pathogenicity of Th17 cells in autoimmune diseasesSeminars in Immunopathology, 2019
- Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory studyJournal of Endocrinological Investigation, 2018
- Metabolism of murine TH17 cells: Impact on cell fate and functionEuropean Journal of Immunology, 2016
- Effect of Iodine Excess on Th1, Th2, Th17, and Treg Cell Subpopulations in the Thyroid of NOD.H-2h4 MiceBiological Trace Element Research, 2014
- Dealing with methionine/homocysteine sulfur: cysteine metabolism to taurine and inorganic sulfurJournal of Inherited Metabolic Disease, 2010
- Metabolism of glucose and glutamine in lymphocytes from graves' hyperthyroid patients: influence of methimazole treatmentCell Biochemistry and Function, 1996